DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Weitz JI, Connolly SJ, Patel I , et al.
Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation.
Thromb Haemost 2010;
104 (3) 633-641
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.